$CGRA CGrowth Capital Provides Business Update and Strategic Planning
CGrowth Capital, Inc. (OTC Pink: CGRA) (the "Company"
, an alternative asset management and emerging growth markets company, is pleased to update the market on current events and strategic planning.
The Company continues to stay focused on expansion plans of its Washington state cannabis facility, securing necessary growth funding, and making progress on its’ NutriLife CBD business launch. Towards that end, the Company included in its business development plans the inclusion of strategic partners and the production of Delta-8 products. Delta-8 is a naturally occurring cannabinoid and derived from hemp, but unlike Delta-9 (THC), it is legalized in the 2018 Farm Bill and it is not prohibited under federal law.